ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
Zhang ZJ, Wu QF, Ren AQ, Chen Q, Shi JZ, Li JP, Liu XY, Zhang ZJ, Tang YZ, Zhao Y, Yao NN, Zhang XY, Liu CP, Dong G, Zhao JX, Xu MJ, Yue YQ, Hu J, Sun F, Liu Y, Ao QL, Zhou FL, Wu H, Zhang TC, Zhu HC.
Zhang ZJ, et al. Among authors: shi jz.
Acta Pharmacol Sin. 2023 Nov;44(11):2282-2295. doi: 10.1038/s41401-023-01108-4. Epub 2023 Jun 6.
Acta Pharmacol Sin. 2023.
PMID: 37280363
Free PMC article.